What does it cost?
A single IV session in Indiana typically runs $325 to $500, and a first course is usually six sessions. Spravato is different, because it is normally billed through insurance.
If you are in crisis, help is available now. Call or text 988 to reach the Suicide & Crisis Lifeline, or text HOME to 741741. If someone is in immediate danger, call 911. This site is information only and cannot provide urgent help.
Independent, sourced information for people in Indianapolis, Fort Wayne, Evansville and across Indiana — written for patients and families, and dated so you can see how current it is.
What it costs in Indiana Does Indiana Health Coverage Programs cover it?
This is an independent information resource. We are not a clinic, not a treatment provider, and not a REMS-certified facility. We cannot book appointments or make referrals. No clinic pays to be listed here.
Answer a few questions and we will show a range — or tell you plainly when we cannot give you a number worth having. Nothing you choose is sent anywhere, and there is nothing to sign up for.
Based on published pricing and coverage rules as of 2019-03-05. Sources for every figure this tool can show:
Indiana Medicaid covers esketamine under published state criteria, set out in bulletin BT202611 and effective for treatment dates from 1 October 2025. Spravato sits in the non-preferred column of the statewide preferred drug list, which means prior approval is required before your plan will pay. as of 22 Jan 2026 · Indiana Family and Social Services Administration (source 1, opens in a new tab)
Best available information: No Indiana clinic we checked publishes a price for intramuscular ketamine, though several offer it. Only a wide band of roughly $200 to $500 a session can be offered, and it is inferred rather than sourced from Indiana price lists. as of 18 Jul 2026 · Viking Psychiatry (source 3, opens in a new tab)The cited clinic lists intramuscular ketamine as an offered route but publishes no cost. The band is inference — you will need to phone.
Cash-pay IV ketamine infusions for depression in Indiana typically run about $325 to $500 a session, with six-infusion starting courses priced around $1,950 to $2,400. as of 18 Jul 2026 · Published Indiana clinic price lists (source 4, opens in a new tab)Prices in the Fort Wayne market in particular are not published at all. The clinic sets the price — treat this as a guide, not a quote.
Best available information: No Indiana clinic we checked publishes a price for sublingual or lozenge ketamine. Nationally, at-home telehealth programmes advertise from roughly $165 to $430 a session, but we have no Indiana figure. as of 5 May 2026 · HealingMaps (source 5, opens in a new tab)This is a national figure from a secondary directory, not an Indiana price. Ask separately what the medicine costs and what the supervised session costs.
Best available information: No Indiana clinic we checked publishes a self-pay price for Spravato. Clinics offering it route the medicine through insurance rather than posting a cash rate, so a self-pay patient has to ask for an individual quote. as of 18 Jul 2026 · Published Indiana clinic pricing pages (source 6, opens in a new tab)Our estimator does not produce a self-pay Spravato figure, because there is no Indiana evidence strong enough to build one on.
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 9, opens in a new tab)
Under Original Medicare Part B in 2026 you pay a $283 yearly deductible first, and after that you generally pay 20% of the Medicare-approved amount for covered services. as of 1 Jan 2026 · Centers for Medicare and Medicaid Services (source 10, opens in a new tab)Deductible and premium amounts are set annually and change each January.
The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 11, opens in a new tab)
Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 14, opens in a new tab)
Best available information: Spravato's list price is not published by the manufacturer or in any free public source. At launch in 2019 the wholesale acquisition cost was around $590 for a 56 mg dose and $885 for an 84 mg dose, and the current list price is very likely higher. as of 5 Mar 2019 · Drugs.com (source 15, opens in a new tab)Wholesale acquisition cost is published only in paywalled pricing compendia. The figures here are seven years old and come from a secondary source, so we do not use them to produce a dollar estimate — the estimator suppresses Spravato cash figures rather than presenting a number this weak.
The Spravato withMe savings programme is not available to anyone using a state or federal government health programme, including Medicare, Medicaid, TRICARE, the Department of Defense, and the Veterans Administration. as of 18 Jul 2026 · Johnson & Johnson (source 16, opens in a new tab)
Through the Spravato withMe savings programme, eligible patients with commercial insurance may pay as little as $10 per treatment for the medicine itself, subject to yearly maximum benefits and quantity limits. as of 18 Jul 2026 · Johnson & Johnson (source 17, opens in a new tab)The programme covers the medicine, not the office visit or the two-hour observation, which is often the larger share of the bill. The official terms state that a yearly maximum applies but do not publish the amount, so we do not either. Terms are set per calendar year.
A single IV session in Indiana typically runs $325 to $500, and a first course is usually six sessions. Spravato is different, because it is normally billed through insurance.
Spravato is generally covered with prior approval, including by Indiana Health Coverage Programs. IV ketamine is off-label and almost never covered, whoever your insurer is.
We list 56 clinicians registered in Indiana whose specialty is associated with ketamine therapy — and we are clear about what that does and does not tell you.
| Treatment | FDA status | Where and how long | Typical course | Insurance | Driving | Typical cash cost |
|---|---|---|---|---|---|---|
| IV ketamine infusion | Not FDA-approved for depression (off-label) | In a clinic, usually 40–60 minutes plus recovery | Typically six sessions over two to three weeks | Almost never covered | You will need someone to drive you home | $325–$500 |
| Spravato (esketamine) | FDA-approved for treatment-resistant depression | Self-administered nasal spray in a certified clinic, with two hours of monitoring | Twice weekly for four weeks, then less often | Usually billed through insurance, with prior approval | No driving until the next day, after a night of restful sleep | Depends on your coverage |
| IM injection | Not FDA-approved for depression (off-label) | In a clinic, shorter than an infusion | Varies by clinic | Almost never covered | You will need someone to drive you home | $200–$500 |
| Sublingual or lozenge | Not FDA-approved for depression (off-label) | At home, or in a supervised session | Varies widely by programme | Almost never covered | Do not drive after a dose | $165–$430 |
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 9, opens in a new tab)
Cash-pay IV ketamine infusions for depression in Indiana typically run about $325 to $500 a session, with six-infusion starting courses priced around $1,950 to $2,400. as of 18 Jul 2026 · Published Indiana clinic price lists (source 4, opens in a new tab)Prices in the Fort Wayne market in particular are not published at all. The clinic sets the price — treat this as a guide, not a quote.
Best available information: No Indiana clinic we checked publishes a price for intramuscular ketamine, though several offer it. Only a wide band of roughly $200 to $500 a session can be offered, and it is inferred rather than sourced from Indiana price lists. as of 18 Jul 2026 · Viking Psychiatry (source 3, opens in a new tab)The cited clinic lists intramuscular ketamine as an offered route but publishes no cost. The band is inference — you will need to phone.
Best available information: No Indiana clinic we checked publishes a price for sublingual or lozenge ketamine. Nationally, at-home telehealth programmes advertise from roughly $165 to $430 a session, but we have no Indiana figure. as of 5 May 2026 · HealingMaps (source 5, opens in a new tab)This is a national figure from a secondary directory, not an Indiana price. Ask separately what the medicine costs and what the supervised session costs.
After a Spravato dose you must not drive or operate machinery until the next day, following a restful night's sleep, so you need to arrange a ride home from every session. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 13, opens in a new tab)
The state's population and medical centre. Indianapolis and its northern suburbs hold most of Indiana's psychiatric and interventional capacity.
Indianapolis · Bloomington · Carmel
Sits in the Chicago metropolitan orbit and on Central Time, so residents often cross the state line for care and compare prices against Illinois clinics rather than Indianapolis ones.
Gary · Hammond
Anchored by Fort Wayne, the state's second-largest city, serving a broad rural catchment toward the Ohio line. Notably, no Fort Wayne clinic we found publishes its prices.
Fort Wayne
Centred on Evansville at the Ohio River, serving a catchment reaching into Kentucky and Illinois, and home to some of the most openly published pricing in the state.
Evansville
South Bend and the surrounding counties near the Michigan line, where patients sometimes look north across the border for options.
South Bend
Providers concentrate in Indianapolis, with smaller groups in Fort Wayne, Evansville and South Bend. Large rural stretches — the east-central counties, the southern hill country below Bloomington, and the north-west agricultural belt outside the Chicago commuter shed — leave one-way drives of 60 to 120 minutes. That compounds across an infusion course of six sessions, and across Spravato's twice-weekly first month, where you cannot drive yourself home from any visit.
Indiana borders MI, OH, KY, IL. A clinic across the border may be closer than one in your own state — but check that it is in your insurance network first, and note that a clinician must be licensed where you receive care.
Indiana medical doctors and osteopathic physicians may administer ketamine within their scope of practice. An advanced practice nurse needs a written collaborative practice agreement with a physician plus state and federal controlled substance registrations before prescribing it. A physician assistant may prescribe and administer only what their collaborating physician has delegated. A certified registered nurse anaesthetist may administer anaesthesia only under a physician's direction and in that physician's immediate presence, and has no independent prescribing authority. as of 1 Jan 2026 · Indiana Professional Licensing Agency (source 1, opens in a new tab)
Indiana Medicaid covers esketamine under published state criteria, set out in bulletin BT202611 and effective for treatment dates from 1 October 2025. Spravato sits in the non-preferred column of the statewide preferred drug list, which means prior approval is required before your plan will pay. as of 22 Jan 2026 · Indiana Family and Social Services Administration (source 1, opens in a new tab)
On 17 January 2025 the FDA approved Spravato for treatment-resistant depression in adults either on its own or together with an oral antidepressant, so a companion oral antidepressant is now optional for this use — though it is still permitted. as of 17 Jan 2025 · U.S. Food and Drug Administration (source 3, opens in a new tab)This applies to the treatment-resistant depression indication only. The separate indication for major depressive disorder with acute suicidal ideation still requires an oral antidepressant — see spravato.approval_mdd_si. Widely-cited secondary sources give 21 January 2025; that is the manufacturer's announcement date, not the FDA action date on the approval letter.
After a Spravato dose you must not drive or operate machinery until the next day, following a restful night's sleep, so you need to arrange a ride home from every session. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 4, opens in a new tab)
Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 3, opens in a new tab)
An Indiana prescriber generally may not issue a controlled substance prescription by telehealth without a prior in-person examination. A statutory exception exists, but it carries its own conditions including a valid controlled substance registration. In practice, expect your first appointment to be in person. as of 1 Jan 2026 · Indiana Code (source 3, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, but they do not override a stricter state rule.
No. Ketamine sits outside both categories Indiana's lookup rule covers, and the rule attaches to prescribing and dispensing rather than to administering — so an infusion given to you inside a clinic falls outside it on a second, independent ground. Dispensing is still reported to INSPECT; it is the prescriber lookup that does not apply. as of 1 Jul 2018 · Indiana Professional Licensing Agency (source 2, opens in a new tab)Material published elsewhere, including a previous version of this site, has stated that Indiana prescribers must check INSPECT before prescribing any controlled substance including ketamine. That is not what the statute says.
An Indiana prescriber generally may not issue a controlled substance prescription by telehealth without a prior in-person examination. A statutory exception exists, but it carries its own conditions including a valid controlled substance registration. In practice, expect your first appointment to be in person. as of 1 Jan 2026 · Indiana Code (source 4, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, but they do not override a stricter state rule.
A comprehensive look at ketamine therapy in Indiana in 2026: how it works, state licensing oversight, insurance options, and how to find a provider.
A practical checklist of questions Indiana patients should ask before choosing a ketamine clinic, from credentials to integration support.
What Indiana's 2026 telehealth framework means for ketamine patients: what can be done remotely, what can't, and how IHCP covers it.